rg 14893 has been researched along with ono 4057 in 2 studies
| Studies (rg 14893) | Trials (rg 14893) | Recent Studies (post-2010) (rg 14893) | Studies (ono 4057) | Trials (ono 4057) | Recent Studies (post-2010) (ono 4057) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 50 | 1 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, PA; Daines, RA; Eggleston, DS; Foley, JJ; Griswold, DE; Haltiwanger, RC; Jakas, DR; Kingsbury, WD; Martin, LD; Pendrak, I | 1 |
| Chambers, PA; Daines, RA; Foley, JJ; Griswold, DE; Jakas, DR; Martin, LD; Pendrak, I; Sarau, HM; Schmidt, DB; Tzimas, MN | 1 |
2 other study(ies) available for rg 14893 and ono 4057
| Article | Year |
|---|---|
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
Topics: Benzoates; Binding, Competitive; Calcium; Crystallography, X-Ray; Cytoplasmic Granules; Humans; Leukotriene B4; Molecular Structure; Neutrophils; Pyridines; Receptors, Leukotriene B4; Structure-Activity Relationship | 1994 |
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Calcium; Humans; Inflammation; Leukotriene B4; Mice; Molecular Structure; Neutrophils; Pyridines; Receptors, Leukotriene B4 | 1993 |